Therefore, our study not only provides new insights into the molecular mechanism of compound-7g’s antiproliferative action, but also offers convincing evidence that pharmacological inactivation of E2F-1-SKP2-p27 axis is a promising approach for tumor treatment. The gene discussed is SKP2; the disease is neoplasm.